Keith Demarest
30Patents
8h-index
48Co-inventors
75Inventor score
Filing activity: Jul 18, 1991 → Apr 7, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6987110B2 | Substituted pyrrolines as kinase inhibitors | Chemistry; Metallurgy | 71 | Expired |
| US6653478B2 | Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators | Chemistry; Metallurgy | 42 | Expired |
| US5532226A | Trifluoromethybenzylphosphonates useful in treating osteoporosis | Chemistry; Metallurgy | 19 | Expired |
| US7425649B2 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | Chemistry; Metallurgy | 14 | Expired |
| US7125878B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 14 | Expired |
| US7750048B2 | GPR40 agonists | Chemistry; Metallurgy | 13 | Active |
| US5300687A | Trifluoromethylbenzylphosphonates useful in treating osteoporosis | Chemistry; Metallurgy | 12 | Expired |
| US6838442B2 | Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators | Human Necessities | 10 | Expired |
| US7598416B2 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | Chemistry; Metallurgy | 8 | Active |
| US6903109B2 | Arylindenopyridines and related therapeutic and prophylactic methods | Chemistry; Metallurgy | 8 | Expired |
| US7928238B2 | 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors | Chemistry; Metallurgy | 7 | Active |
| US7678786B2 | Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol | Chemistry; Metallurgy | 6 | Active |
| US6828327B2 | Macroheterocylic compounds useful as kinase inhibitors | Chemistry; Metallurgy | 6 | Expired |
| US7232906B2 | Substituted pyrrolines as kinase inhibitors | Chemistry; Metallurgy | 5 | Expired |
| US7351857B2 | Methods of using substituted tetralins and indanes | Chemistry; Metallurgy | 1 | Expired |
| US7825110B2 | Substituted spiroheterocycles | Human Necessities | 1 | Active |
| US7781450B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 1 | Active |
| US7786135B2 | Substituted pyrroline kinase inhibitors | Human Necessities | 1 | Active |
| US8278268B2 | Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators | Human Necessities | 0 | Active |
| US8242173B2 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | Chemistry; Metallurgy | 0 | Active |
| US7749995B2 | 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7875744B2 | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | Chemistry; Metallurgy | 0 | Active |
| US7825111B2 | Substituted spiroheterocycles | Human Necessities | 0 | Active |
| US8183213B2 | Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators | Human Necessities | 0 | Active |
| US8633184B2 | Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.